https://acuity.news/technology/floreo-vr-autism-therapy-fda-de-novo-review-2026/Acuity Newsen2026-09-11T11:58:00-06:00Floreo’s FDA Decision on Its VR Autism Therapy Lands This Fall. CEO Vijay Ravindran Says the Pivotal Trial’s Most Striking Result Showed Up in the Parents. https://acuity.news/regulation/injectable-buprenorphine-buy-and-bill-addiction-treatment-economics-2026/Acuity Newsen2026-09-11T07:55:26-06:00Addiction Treatment Is Shifting From a Daily Pill to a Monthly Shot, and the Economics Are Shifting With It. Long-Acting Injectables Turn Medication Into a Billable Clinical Service. https://acuity.news/regulation/direct-support-professional-dsp-workforce-crisis-medicaid-2026/Acuity Newsen2026-09-10T06:33:59-06:00The Workforce That Autism and Disability Services Depend On Is Collapsing, and Almost No One Outside the Field Has Noticed. Direct Support Professionals Are Leaving Faster Than They Can Be Replaced.